Global Bioenergies : Financial visibility out to end-2020
>H1 results - Global Bioenergies has reported its H1 2019 data, the operating loss totalled -€ 7.5m (vs -€ 8.5m in 2018) notably thanks to tight control of operating costs at € 8.9m (-3.5% y-o-y). The net loss stood at € 7.58m (vs € 8.8m in H1 2018).€ 20.8m in cash at end-June - Global Bioenergies had € 20.8m mid-year in cash vs € 10.3m at end-2018 including the proceeds from the € 17m capital increase completed in June. A cash position which offers ...Global Bioenergies SA is a France-based company that specializes in the development of a process to produce isobutene biologically from renewable resources. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. It distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. It operates through Syngip.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.